Expansion of germline genetic testing criteria for prostate cancer yields findings across all stages of disease.

e17615Background: Increasing evidence suggests criteria for germline testing of patients with prostate cancer (PCa) may miss potentially actionable pathogenic variants. A sponsored testing program ...